Cardiac homeobox gene NKX2-5 mutations and congenital heart disease
Associations with atrial septal defect and hypoplastic left heart syndrome
David A. Elliott, PhD*,
Edwin P. Kirk, MBBS* ,
Thomas Yeoh, MBBS*,
Suchitra Chandar, MBBS*,
Fiona McKenzie, MBBS ,
Peter Taylor, BAppSc ,
Paul Grossfeld, MD||,
Diane Fatkin, MD*,
Owen Jones, MBBS ,
Peter Hayes, MBBS*,
Michael Feneley, MD* and
Richard P. Harvey, PhD* ,*
* Victor Chang Cardiac Research Institute, Sydney, Australia
Sydney Childrens Hospital, Sydney, Australia
University of New South Wales, Sydney, Australia
Hunter Genetics, Newcastle, Australia
|| University of California at San Diego/Childrens Hospital, San Diego, California, USA


View larger version (46K):
[in a new window]
|
Figure 1 Families with atrial septal defect (ASD) and NKX2-5 changes. (A) Family 1024, showing ASD and hypoplastic left heart syndrome (HLHS). NlaIII restriction enzyme analysis of polymerase chain reaction products (bottom) demonstrated that all affected and one unaffected individual (II-4) carried the C642T mutation. (B) Family AF1, showing ASD over three generations. Among affected individuals genotyped (I-2, II-2, III-2), only III-2 carried the C171G polymorphism. Sequence traces are shown. (C) Schematic representation of the NKX2-5 protein, showing functional domains and detected aa changes. TN = TN domain; HD = homeodomain; NK2SD = NK2-specific domain.
|
|
|